Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-05 · accession 0001048477-24-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-07 | 2024-03-05 | BMRN | FUCHS HENRY J | Pres, Worldwide R, D | S - Sale | $85.18 | -35.3K | 212.1K | -14% | -$3.01M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | S | D | 35,341 | $85.18 | 212,117 | D | — | — | (F1) The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.01 to $85.31. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price. |